ZEPP R&D to Revenue
Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares · R&D to Revenue
ZEPP R&D to Revenue
Latest reported17.50%period ending
ZEPP FY R&D/Revenue (6.87% → 17.50%)
Latest values, visible window
High-resolution chart · PNG
ZEPP r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 17.5043% | |
| 25.2783% | |
| 14.5959% | |
| 12.4822% | |
| 8.2412% | |
| 8.3628% | |
| 7.4123% | |
| 7.2207% | |
| 7.5078% | |
| 8.5002% | |
| 6.8662% |